Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

11
Number of overlapping holdings
26.8%
% of HRTS's 42 holdings also in HART
16.7%
% of HART's 75 holdings also in HRTS
Overlap by Weight
Sector Drift (HRTS minus HART)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in HRTS |
Weight in HART |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 9.7% | 5.4% | 5.4% | |
ABBOTT LABORATORIES | 4.7% | 5.7% | 4.7% | |
ASTRAZENECA PLC | 4.1% | 5.6% | 4.1% | |
NOVO NORDISK A/S-B | 4.1% | 4.0% | 4.0% | |
BOSTON SCIENTIFIC CORP | 3.3% | 5.4% | 3.3% |
Position Highlights (Non-Overlapping Exposures)
HRTS Overweight Relative to HART
UNITEDHEALTH GROUP INC | 4.7% | |
ELI LILLY & CO | 4.3% | |
ROCHE HOLDINGS LTD-SPONS ADR | 3.8% | |
BRIDGEBIO PHARMA, INC. | 3.2% | |
VERTEX PHARMACEUTICALS INC | 3.2% | |
GILEAD SCIENCES INC | 2.9% | |
CRINETICS PHARMACEUTICALS INC | 2.8% | |
CHUGAI PHARMACEUTICAL CO LTD | 2.7% | |
THERMO FISHER SCIENTIFIC INC | 2.7% | |
MERCK & CO. INC. | 2.4% |
HRTS Underweight Relative to HART
JOHNSON & JOHNSON | -5.3% | |
ALPHABET INC. CLASS A | -5.0% | |
PFIZER INC | -5.0% | |
APPLE INC | -4.9% | |
SANOFI-AVENTIS | -4.0% | |
BRISTOL-MYERS SQUIBB CO | -2.9% | |
ELEVANCE HEALTH INC | -2.8% | |
NIKE INC -CL B | -2.7% | |
MEDTRONIC PLC | -2.3% | |
NOVARTIS AG | -2.2% |